Next Science

Next ScienceTM pioneers innovative, proprietary technologies to address the problem of biofilm. With proven, experienced management and scientific leadership, Next Science and its partners deliver break-through solutions that see beyond the current limits imposed by powerful bacterial colonies. Next Science offers a new solution to the biofilm problem with a proprietary, non-toxic technology that disrupts the biofilms extracellular polymeric substance (EPS) matrix and, unlike competitors, offers no known opportunity for bacterial resistance. Recent clinical studies and field evaluations have shown Next Science products advance healing, reduce the number of bacteria present, and regardless of setting, help to prevent the growth...

Biotechnology,biofilm eradication,healthcare,infection prevention,wound care,antimicrobial,surgical site infection,and surgery

Next science operates in the Biotechnology research industry.

Next science's revenue is 11m - 100m

Next science has 51 - 200 employees.